The Defense Advanced Research Projects Agency’s Pharmacy on Demand (PoD) program seeks research on devices and techniques needed to manufacture small molecule pharmaceuticals. Devices need to be capable of manufacturing a variety of drugs using shelf-stable precursors and initial prototypes. Ideally, they should be operable from the back of a mobile platform, such as a High Mobility Multipurpose Wheeled Vehicle (HMMWV).
DARPA proposals are to be submitted in three technical areas:
• Technical area 1 needs to demonstrate the capability to manufacture pharmaceutical agents with a variety of battlefield uses.
• Technical area 2 seeks development of lab-on-a-chip and plant-on-a-chip or similar technologies
• Technical area 3 needs to demonstrate how to consistently manufacture pharmaceutical agents in technical area 1 with the same purity and efficacy as comparable to commercial products
Individual multiple awards will be made and may be in the form of procurement contracts, grants, cooperative agreements or some other type of transaction. Funding will be determined by the quality of the proposals received and the availability of funds.
Proposal Abstracts are due December 1, 2010 with full proposals due January 11, 2011. The funding opportunity number is DARPA-BAA-11-05. For more information email Geoffrey Ling at DARPA-BAAfirstname.lastname@example.org. To download the solicitation, go to www.fbo.gov.